Why did Amazon Web Services outage disrupt global websites?
How will Japan’s first female prime minister impact markets?
What caused Apple’s iPhone 17 sales surge?
Why is Cleveland-Cliffs expanding into rare earth mining?
How does Trump’s Argentina beef deal affect US prices?
What’s behind the split between OpenAI and Microsoft?
Why is CleanSpark pivoting from bitcoin to AI infrastructure?
Johnson & Johnson Reports Strong Phase 3 Results For Multiple Myeloma Therapy
benzinga.com/news/health-care/25/10/48258803/johnson-johnsons-multiple-myeloma-patients
On Thursday, Johnson & Johnson (NYSE:JNJ) announced positive topline results from a recent study.
The company’s Phase 3 MajesTEC-3 trial is evaluating Tecvayli (teclistamab-cqyv) in combination with Darzalex Faspro (daratumumab and hyaluronidase-fihj) for patients with relapsed or…
This story appeared on benzinga.com, 2025-10-16 17:37:03.